Compliance and Efficacy in the Use of PICOPREP® (CLEAR)
Compliance and Efficacy in the Use of PICOPREP® for Bowel Cleansing
Sponsor: Ferring Arzneimittel GmbH
Listed as NCT01220453, this observational or N/A phase trial focuses on Bowel Cleanliness and remains completed. Sponsored by Ferring Arzneimittel GmbH, it has been updated 8 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
▶ Show 3 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Feb 2017 — Apr 2018 [monthly]
Completed NA
-
Jan 2017 — Feb 2017 [monthly]
Completed NA
First recorded
Oct 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ferring Arzneimittel GmbH
- Ferring Pharmaceuticals
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Altdorf, Germany , Altenholz, Germany , Augsburg, Germany , Bad Lausick, Germany , Bad Schwalbach, Germany , Bayreuth, Germany , Beckum, Germany , Berlin, Germany , Bielefeld, Germany , Bietigheim, Germany and 111 more locations